rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Dario Scimeca

General Counsel and Secretary

Company insider

Files Form 4 as: General Counsel and Secretary, Precision BioSciences.

In numbers

Trades disclosed
82
Buys
0
Sells
13
Bought
$0
Sold
$224K
Companies
1
Companies where not an officer
0
First trade
4 Jul 2019
Last trade
1 Jun 2026
Last filed
3 Jun 2026

Companies traded

Where they are an officer
DTIL Precision BioSciencesOfficer · Biotechnology · last 1 Jun 20260 buys · 13 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 Jun 2026filed 3 Jun 2026DTIL Precision BioSciencesoption or derivative · BiotechnologySEC FORM 4 Code A—107,604 at $0.00filing
1 Jun 2026filed 3 Jun 2026DTIL Precision BioSciencesoption or derivative · BiotechnologySEC FORM 4 Code A—107,604 at $0.00filing
18 Feb 2026filed 19 Feb 2026DTIL Precision BioSciencesBiotechnologySEC FORM 4 Sold$19K4,925 at $3.84filing
18 Feb 2026filed 19 Feb 2026DTIL Precision BioSciencesBiotechnologySEC FORM 4 Sold$19K4,925 at $3.84filing
17 Feb 2026filed 19 Feb 2026DTIL Precision BioSciencesBiotechnologySEC FORM 4 Code M—16,667 at $0.00filing
17 Feb 2026filed 19 Feb 2026DTIL Precision BioSciencesoption or derivative · BiotechnologySEC FORM 4 Code M—16,667 at $0.00filing
17 Feb 2026filed 19 Feb 2026DTIL Precision BioSciencesoption or derivative · BiotechnologySEC FORM 4 Code M—16,667 at $0.00filing
17 Feb 2026filed 19 Feb 2026DTIL Precision BioSciencesBiotechnologySEC FORM 4 Code M—16,667 at $0.00filing
21 Jan 2026filed 22 Jan 2026DTIL Precision BioSciencesBiotechnologySEC FORM 4 Sold$36K8,854 at $4.03filing
21 Jan 2026filed 22 Jan 2026DTIL Precision BioSciencesBiotechnologySEC FORM 4 Sold$36K8,854 at $4.03filing
20 Jan 2026filed 22 Jan 2026DTIL Precision BioSciencesBiotechnologySEC FORM 4 Code M—1,978 at $0.00filing
20 Jan 2026filed 22 Jan 2026DTIL Precision BioSciencesBiotechnologySEC FORM 4 Code M—8,425 at $0.00filing
20 Jan 2026filed 22 Jan 2026DTIL Precision BioSciencesBiotechnologySEC FORM 4 Code M—14,908 at $0.00filing
20 Jan 2026filed 22 Jan 2026DTIL Precision BioSciencesoption or derivative · BiotechnologySEC FORM 4 Code M—1,978 at $0.00filing
20 Jan 2026filed 22 Jan 2026DTIL Precision BioSciencesoption or derivative · BiotechnologySEC FORM 4 Code M—8,425 at $0.00filing
20 Jan 2026filed 22 Jan 2026DTIL Precision BioSciencesoption or derivative · BiotechnologySEC FORM 4 Code M—14,908 at $0.00filing
20 Jan 2026filed 22 Jan 2026DTIL Precision BioSciencesoption or derivative · BiotechnologySEC FORM 4 Code M—1,978 at $0.00filing
20 Jan 2026filed 22 Jan 2026DTIL Precision BioSciencesoption or derivative · BiotechnologySEC FORM 4 Code M—8,425 at $0.00filing
20 Jan 2026filed 22 Jan 2026DTIL Precision BioSciencesoption or derivative · BiotechnologySEC FORM 4 Code M—14,908 at $0.00filing
20 Jan 2026filed 22 Jan 2026DTIL Precision BioSciencesBiotechnologySEC FORM 4 Code M—1,978 at $0.00filing

News

Precision BioSciences, Inc. (NASDAQ:DTIL) Stock Has Consensus Price Target of $32.25DTIL · themarketsdaily.com · 17 Oct 2026

0 headlines in the last 90 days name Dario Scimeca; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care13

Buys in green, sells in red, by the company’s sector.

Related people

Stanley FrankelDirector · Director at Precision Biosciences, filing Form 4 there in the last year
Geno J. GermanoDirector · Director at Precision Biosciences, filing Form 4 there in the last year
Melinda BrownDirector · Director at Precision Biosciences, filing Form 4 there in the last year
Shari Lisa PireDirector · Director at Precision Biosciences, filing Form 4 there in the last year
Kevin BuehlerDirector · Director at Precision Biosciences, filing Form 4 there in the last year